BPH Energy Ltd
BPH.AU
$0.01
Closing
▲10.00%
1D
▼-53.19%
YTD
Market cap
$15.69M
52 week high
$0.05
52 week low
$0.01
Volume
1,900,352
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$15.69M
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
22.45
Operating Margin
-456.69%
Beta
1.29
Revenue Growth (Annual)
82.36%
52 week high
$0.05
52 week low
$0.01
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
BPH Energy Limited is an Australia-based diversified company holding investments in resources and medical technology. The Company holds a significant interest in an unlisted oil and gas exploration company. The Company’s principal activities include investments in various companies, which include Clean Hydrogen Technologies Corporation (Clean Hydrogen Technologies), Cortical Dynamics Limited (Cortical), Advent Energy Limited, and Molecular Discovery Systems Limited (MDSystems). Clean Hydrogen Technologies is a USA Delaware registered company with technology to produce clean hydrogen. Advent Energy Limited is an unlisted oil and gas exploration and production company based in Perth, Western Australia. Cortical is a medical device company focused on developing brain function monitors by employing theories and technologies in the field. MDSystems focuses on drug discovery and the validation of biomarkers for disease, therapy and diagnostics.
